ArticleAmerican journal of hematology2025

Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.

Naseema Gangat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.